Dyne Therapeutics

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

We are fearless innovators on a mission to deliver functional improvement for individuals, families and communities. We pursue our goals with passion, determination, agility and urgency, recognizing that countless lives depend on our efforts. We are here to forever change lives. We know we will deliver.

1560 Trapelo Road
Waltham, MA 02451
  • Featured Employer

We’re looking for colleagues who share this ethos to join Dyne and help shape one of the most innovative and impactful biotech companies. If you’re driven to deliver for people living with neuromuscular diseases; if you put team and mission first; if you embrace bold ideas; if you are committed to accountability and transparency; if you have a drive to make a difference, we’d love to connect.

Discover our open positions

Hear from our Dynamos

We are on a mission to deliver functional improvement for individuals, families, and communities. The foundation of our efforts is driven by our exceptional team of Dynamos and their dedication to fostering an unparalleled culture. Hear Dynamos share their perspectives on their biotech careers and what makes Dyne a special place to work.

Collaborative Culture
On Now
Collaborative Culture
On Now
Commitment to Innovation
On Now
Passionate and Driven Team
NEWS
Average jobs live on BioSpace increased year over year in October, a good sign for those eyeing a new position. If that’s you, check out the list of which companies are most actively looking to hire.
Looking for a remote biopharma position? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat spinal muscular atrophy and Alexander disease.
Of the 38 companies receiving incentives, 31 will expand outside of Boston and Cambridge. Still, Boston and Cambridge are each expected to gain over 200 jobs. Tax incentive award recipients include AstraZeneca, Bristol Myers Squibb and Insulet.
As biopharma job openings rose this year, opportunities were greatest in Massachusetts and California and in the science/R&D and clinical disciplines, according to BioSpace data. Several other locations and functions have also been going strong.
From engineering to science/R&D, these top seven biopharma disciplines each have hundreds, and in one case over 1,000, positions posted on BioSpace.
If approved, Dyne Therapeutics’ zeleciment rostudirsen could “capture the majority” of the exon-51 Duchenne muscular dystrophy market, given its better efficacy and dosing profile versus Sarepta Therapeutics’ exon-skipping therapy Exondys 51, the current standard of care, according to Oppenheimer.
Looking for a job in Boston? Here’s a list of 7 companies on BioSpace currently hiring biopharma roles in Boston–plus a few more hiring in Waltham and Weston.
Analysts homed in on Duchenne muscular dystrophy and myotonic dystrophy type 1 assets during first quarter earnings as major players like REGENXBIO and Novartis as well as Dyne, Wave, Solid and Sarepta near the regulatory finish line.
JOBS
IN THE PRESS